Financial News · Live Terminal

Page 1405 of 2557

UBS Adjusts Price Target on Sabra Health Care REIT to $22 From $21, Maintains Neutral Rating

Sabra Health Care REIT (SBRA) has an average rating of overweight and mean price target of $22.31, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $20.96, Change: $-0.02, Percent Change: -0.07%

$SBRA

Insider Trading54d ago

Update: Millrose Properties Insider Bought Shares Worth $6,418,320, According to a Recent SEC Filing

Darren Richman, Chief Executive Officer and President, on May 11, 2026, executed a purchase for 235,000 shares in Millrose Properties (MRP) for $6,418,320. Following the Form 4 filing with the SEC, Richman has control over a total of 500,000 Class A common shares of the company, with 416,000 shares held directly and 84,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2017206/000119312526220813/xslF345X05/ownership.xmlPrice: $27.12, Change: $+0.51, Percent Change: +1.94%

$MRP

Insider Trading54d ago

Millrose Properties Insider Bought Shares Worth $6,418,320, According to a Recent SEC Filing

Darren Richman, Chief Executive Officer and President, on May 11, 2026, executed a purchase for 235,000 shares in Millrose Properties (MRP) for $6,418,320. Following the Form 4 filing with the SEC, Richman has control over a total of 500,000 common shares of the company, with 416,000 shares held directly and 84,000 controlled indirectly.SEC Filing:https://www.sec.gov/Archives/edgar/data/2017206/000119312526220813/xslF345X05/ownership.xmlPrice: $26.87, Change: $+0.26, Percent Change: +1.00%

$MRP

Mining & Metals54d ago

Update: AtkinsRealis to Buy Ireland-Based Firm TOBIN; Signs 20-Year Agreement for Engineering Services With First American Nuclear

(Updates to add acquisition of TOBIN and shares)AtkinsRealis Group (ATRL.TO) entered into a definitive agreement to acquire Patrick J Tobin & Co. Ltd. (TOBIN), a leading Irish engineering and project management consultancy firm, it said Wednesday. No financial details were given."The acquisition supports AtkinsRealis' growth strategy in Ireland, further strengthening its local footprint to over 700 employees and bolstering its capabilities to support Ireland's ambitious program of infrastructure development," the company said in a statement.Meanwhile, earlier Wednesday, the company also signed a Strategic Alliance agreement with First American Nuclear (FANCO) whereby the company will act as the exclusive engineering, procurement, and construction management (EPCM) provider for EAGL-1 small modular reactor (SMR) projects in North America.Work has begun on the task orders, and the agreement contemplates services worth up to $250 million over the first five years, it said. Under the first task orders, AtkinsRealis will prepare procedures and policies required to do design work, such as a quality program and engineering procedures.The company will also undertake the conceptual design for the balance of plant and review the design of the nuclear steam supply system.Shares of the company were last seen down 0.9% at $88.12 on the Toronto Stock Exchange.Price: $87.79, Change: $-1.11, Percent Change: -1.25%

$ATRL.TO

Asia54d ago

Smruthi Organics Clocks Sharp Decline in Fiscal Q4 Net Profit

Smruthi Organics' (BOM:540686) net profit more than halved to 10.7 million Indian rupees in the fiscal fourth quarter from 22.3 million rupees a year earlier, according to an Indian bourse filing on Wednesday.Earnings per share for the quarter ended March 31 contracted to 0.93 rupees from 1.95 rupees a year ago.The pharmaceutical company's revenue slipped year-on-year to 290.9 million rupees from 380.9 million rupees, the filing said.The company's board recommended a dividend of 1.5 rupees per share for fiscal 2026 ended March 31.Shares of the company were up 4% in after-market hours.

BOM:540686

Insider Trading54d ago

Waste Connections Insider Bought Shares Worth $7,611,750, According to a Recent SEC Filing

Ronald J Mittelstaedt, Director, President and Chief Executive Officer, on May 12, 2026, executed a purchase for 50,000 shares in Waste Connections (WCN) for $7,611,750. Following the Form 4 filing with the SEC, Mittelstaedt has control over a total of 301,017 common shares of the company, with 301,017 shares held directly.SEC Filing:https://www.sec.gov/Archives/edgar/data/1318220/000106429926000005/xslF345X05/primarydocument.xmlPrice: $151.67, Change: $+0.42, Percent Change: +0.28%

$WCN

Asia54d ago

Market Chatter: Danantara Eyes Stake in Indonesia Nickel Mine Project

Indonesia's sovereign wealth fund confirmed early-stage talks to buy Eramet's stake in the Weda Bay nickel project in the country, The Jakarta Globe reported Wednesday.Danantara CEO Rosan Roeslani was also quoted in the report as saying that the fund is "open for talks" on investments and local partnerships in Indonesia.PT Weda Bay Nickel is owned 51.3/37.8/10 by China's Tsingshan, French miner Eramet, and Indonesian state-owned PT Antam (IDX:ANTM), according to the joint venture's website.Eramet did not immediately respond to a request for comment from.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

IDX:ANTM

Wire54d ago

UBS Adjusts Price Target on Sleep Number to $2 From $4, Maintains Neutral Rating

$SNBR

Wire54d ago

UBS Trims Price Target on Syndax Pharmaceuticals to $37 From $38, Maintains Buy Rating

Syndax Pharmaceuticals (SNDX) has an average rating of buy and mean price target of $39.25, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $20.29, Change: $-0.12, Percent Change: -0.59%

$SNDX

Wire54d ago

UBS Adjusts Price Target on Janus International Group to $6 From $7.25, Maintains Neutral Rating

Janus International Group (JBI) has an average rating of overweight and mean price target of $7.70, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $4.86, Change: $-0.11, Percent Change: -2.12%

$JBI

Wire54d ago

UBS Cuts Price Target on MercadoLibre to $1,750 From $2,050, Maintains Neutral Rating

MercadoLibre (MELI) has an average rating of buy and mean price target of $2,305.61, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $1498.94, Change: $-79.84, Percent Change: -5.06%

$MELI

Wire54d ago

UBS Raises Healthpeak Properties Price Target to $19 From $17, Neutral Rating Kept

Healthpeak Properties (DOC) has an average rating of overweight and mean price target of $19.88, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $19.45, Change: $-0.32, Percent Change: -1.62%

$DOC

Wire54d ago

Planet Labs Unit Signs Two-Year Contract With Czech Agency

Planet Labs (PL) said Wednesday its Sinergise Solutions unit has signed a two-year, seven-figure contract with the Czech Republic's State Agricultural Intervention Fund to provide satellite imagery and artificial intelligence-based analytics for agricultural monitoring.Exact financial terms of the deal were not provided.The company said the agreement is expected to support the country's agricultural payments and monitoring system and cover about 25,000 farming operations.Planet said the project will combine its satellite data with analytics developed alongside Asseco Group to automate monitoring and validation of activities, including crop identification and harvest timing.Shares of the company were down 2.6% in Wednesday trading.Price: $39.77, Change: $-0.93, Percent Change: -2.29%

$PL

Oil & Energy54d ago

US Natural Gas Update: Futures Rise Nearly 2% Amid Middle East Stalemate, Bullish Weather Forecasts

US natural gas futures rallied on Wednesday as Middle East supply constraints persisted, helping offset bearish domestic developments.Both the front-month Henry Hub contract and the continuous contract rose 1.83% to $2.895 per million British thermal units.The conflict in the Middle East has reached a stalemate, with US President Donald Trump rejecting Iran's response to a US-backed ceasefire proposal earlier this week.Meanwhile, Iran's Foreign Minister Seyyed Abbas Araghchi said on Tuesday that the country was developing a new set of rules to facilitate safe passage via the Strait of Hormuz, cementing its control over the strategically crucial waterway.This helped offset a prediction of higher US gas output with the US Energy Information Administration raising its 2026 natural gas production estimates to 110.61 billion cubic feet per day, from a projection of 109.60 bcf per day in April.LNG export feedgas demand, too, has dropped to 17.29 Bcf, compared to the 30-day moving average of 18.82 Bcf, according to the Bloomberg LNG Feedgas Model. This is primarily due to seasonal maintenance planned across several leading LNG export facilities.Weather forecasts, however, have turned bearish, with almost the whole of the country expected to see above-normal temperatures from May 20 to May 26, according to the National Weather Service. This is expected to kickstart air conditioning demand with temperatures across parts of the country set to top 90 degrees.

Wire54d ago

UBS Adjusts Aramark Price Target to $56 From $48, Maintains Buy Rating

Aramark (ARMK) has an average rating of overweight and mean price target of $52.50, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $49.10, Change: $+0.70, Percent Change: +1.45%

$ARMK

Asia54d ago

GlaxoSmithKline Pharmaceuticals Clocks Higher Fiscal Q4 Consolidated Net Profit

GlaxoSmithKline Pharmaceuticals (NSE:GLAXO, BOM:500660) consolidated net profit increased to 2.78 billion Indian rupees in the quarter ended March 31 against 2.63 billion rupees a year ago.Earnings per share rose to 16.40 rupees from 15.52 rupees, according to post-market hours filing on Wednesday.Revenue from operations in fiscal Q4 increased to 9.95 billion rupees from 9.74 billion rupees in the corresponding quarter of the previous fiscal year.The board of the company recommended a dividend of 57 rupees per share for the financial year ended March 31.

BOM:500660NSE:GLAXO

Wire54d ago

AngioDynamics Reports 'Durable Oncologic Control' in Study of NanoKnife for Intermediate-Risk Prostate Cancer

AngioDynamics (ANGO) shares were up close to 3% in Wednesday trading after it said two-year results from the PRESERVE pivotal trial demonstrated "durable oncologic control and a sustained safety profile" for its NanoKnife System for prostate tissue ablation in patients with intermediate-risk prostate cancer.The study is evaluating focal irreversible electroporation using the NanoKnife System in 121 patients with Gleason Grade Group 2-3 intermediate-risk prostate cancer.The company's NanoKnife System, which uses irreversible electroporation, is intended to reduce quality of life complications, according to a study archived by the National Institutes of Health's National Library of Medicine.Shares of AngioDynamics were up close to 3% in Wednesday trading.Price: $10.94, Change: $+0.04, Percent Change: +0.37%

$ANGO

Wire54d ago

UBS Adjusts Price Target on AnaptysBio to $76 From $70, Maintains Buy Rating

AnaptysBio (ANAB) has an average rating of buy and mean price target of $54.85, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $61.13, Change: $-4.45, Percent Change: -6.79%

$ANAB

Wire54d ago

UBS Adjusts Price Target on AMN Healthcare Services to $32 From $19.5, Maintains Neutral Rating

AMN Healthcare Services (AMN) has an average rating of overweight and mean price target of $21.64, according to analysts polled by FactSet.(covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may contact us here: https://www..com/contact-us)Price: $29.38, Change: $-0.11, Percent Change: -0.39%

$AMN

Equities54d ago

Neste Completes Tender Offers for Three Series of Green Notes

Neste (NESTE.HE) said Wednesday it has completed its tender offer for notes due 2028, 2029, and 2030.The Finnish oil refiner detailed the pricing of its 500 million-euro 0.75% green notes due March 25, 2028, 500 million-euro 3.875% green bonds due March 16, 2029, and 700 million-euro 3.75% green bonds due March 20, 2030.The settlement date is set on May 18.

$NESTE.HE

Showing 28081-28100 of 51135